Literature DB >> 18763000

Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance.

E Fréalle1, K Decrucq, F Botterel, B Bouchindhomme, D Camus, E Dei-Cas, J M Costa, I Yakoub-Agha, S Bretagne, L Delhaes.   

Abstract

In order to improve invasive pulmonary aspergillosis (IPA) diagnosis, a real-time polymerase chain reaction (PCR) assay detecting Aspergillus spp. was developed. Its detection limit reached 2-20 conidia. The retrospective evaluation on 64 bronchoalveolar lavage (BAL) fluids from 57 patients at risk for IPA, including 20 probable and five proven IPA patients, revealed a 88% or 38% sensitivity in direct examination (DE)/culture-positive or culture-negative BAL, respectively, whereas galactomannan (GM) sensitivity reached 88% or 58%, respectively. Influence on the Aspergillus-PCR yield of BAL fluid volume, cellular count and DNA content (evaluated by human beta-globin quantification) was assessed. Significantly higher beta-globin levels were detected in Aspergillus PCR-positive (median 5,112 pg/microl) than negative (median 1,332 pg/microl) BAL fluids, suggesting that the beta-globin level could reflect BAL yields and DNA extraction. Using beta-globin for the interpretation of fungal PCR could improve the negative predictive value of this test.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763000     DOI: 10.1007/s10096-008-0616-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  40 in total

1.  Guidelines of the Papanicolaou Society of Cytopathology for the examination of cytologic specimens obtained from the respiratory tract. Papanicolaou Society of Cytopathology Task Force on Standards of Practice.

Authors: 
Journal:  Diagn Cytopathol       Date:  1999-07       Impact factor: 1.582

2.  Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis.

Authors:  Martin J Becker; Elly J Lugtenburg; Jan J Cornelissen; Cindy Van Der Schee; Henk C Hoogsteden; Siem De Marie
Journal:  Br J Haematol       Date:  2003-05       Impact factor: 6.998

3.  Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis.

Authors:  Maurizio Sanguinetti; Brunella Posteraro; Livio Pagano; Gabriella Pagliari; Luana Fianchi; Luca Mele; Marilena La Sorda; Angelica Franco; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 4.  Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; J Peter Donnelly; Paul E Verweij
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

5.  Development of a nested qualitative real-time PCR assay to detect Aspergillus species DNA in clinical specimens.

Authors:  Catriona Halliday; Qi Xuan Wu; Gregory James; Tania Sorrell
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood.

Authors:  J Löffler; H Hebart; U Schumacher; H Reitze; H Einsele
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  Detection and identification of fungal pathogens in blood by using molecular probes.

Authors:  H Einsele; H Hebart; G Roller; J Löffler; I Rothenhofer; C A Müller; R A Bowden; J van Burik; D Engelhard; L Kanz; U Schumacher
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

8.  Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections.

Authors:  C Ferrer; F Colom; S Frasés; E Mulet; J L Abad; J L Alió
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

9.  Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.

Authors:  Benjamin Musher; David Fredricks; Wendy Leisenring; S Arunmozhi Balajee; Caitlin Smith; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

10.  Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.

Authors:  Ana C Vallor; William R Kirkpatrick; Laura K Najvar; Rosie Bocanegra; Marsha C Kinney; Annette W Fothergill; Monica L Herrera; Brian L Wickes; John R Graybill; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

View more
  13 in total

1.  Advances and prospects for molecular diagnostics of fungal infections.

Authors:  Stéphane Bretagne
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

Review 2.  Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.

Authors:  Tomer Avni; Itzhak Levy; Hannah Sprecher; Dafna Yahav; Leonard Leibovici; Mical Paul
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

Review 3.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 4.  PCR-based diagnosis of human fungal infections.

Authors:  Prasanna D Khot; David N Fredricks
Journal:  Expert Rev Anti Infect Ther       Date:  2009-12       Impact factor: 5.091

5.  The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.

Authors:  Laurence Delhaes; Sébastien Monchy; Emilie Fréalle; Christine Hubans; Julia Salleron; Sylvie Leroy; Anne Prevotat; Frédérick Wallet; Benoit Wallaert; Eduardo Dei-Cas; Telesphore Sime-Ngando; Magali Chabé; Eric Viscogliosi
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia.

Authors:  Michael Boeckh; Terry Stevens-Ayers; Giovanna Travi; Meei-Li Huang; Guang-Shing Cheng; Hu Xie; Wendy Leisenring; Veronique Erard; Sachiko Seo; Louise Kimball; Lawrence Corey; Steven A Pergam; Keith R Jerome
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 7.759

Review 7.  Evaluation of PCR on bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis: a bivariate metaanalysis and systematic review.

Authors:  Wenkui Sun; Ke Wang; Wei Gao; Xin Su; Qian Qian; Xin Lu; Yong Song; Yaling Guo; Yi Shi
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

8.  Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

Authors:  Koen de Heer; Marije G Gerritsen; Caroline E Visser; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

Review 9.  Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis.

Authors:  Mingxiang Zou; Lanhua Tang; Shushan Zhao; Zijin Zhao; Luyao Chen; Peng Chen; Zebing Huang; Jun Li; Lizhang Chen; Xuegong Fan
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

Review 10.  Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome.

Authors:  Richard C Barton
Journal:  Scientifica (Cairo)       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.